PI-LAB-2025-114

GHK-Cu, Independent Lab Report

GHK-Cu 10mg · Cascade Research Group

Failed

Independent testing verdict Fail

This product failed independent verification.

Sample failed verification: 69.1% measured purity against a ≥95% claim, with 97.0% of labelled content.

Identity verified
No

The labelled compound was not confirmed

Measured purity
69.1%

Label claimed ≥95%

Content accuracy
97%

9.7mg measured against 10mg claimed

Test recency
Current cycle

Published 11 months ago

Specimen PI-LAB-2025-114 Tested by Vantage Analytical Labs 9 samples tested from this company Purity & Testing score 9/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 95% 69.1% Fails claim
Identity (MS) GHK-Cu Not confirmed Identity failure
Content 10 mg 9.7 mg Within 5% of label

Methodology & chain of custody

HPLC-UV purity, ESI-MS identity, and Karl Fischer water content.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Vantage Analytical Labs. See our full testing methodology.

Lot / batch
A9914-25
Purchased
Analysed
Published
Laboratory
Vantage Analytical Labs
Test type
Content verification

Testing notes

Result confirmed on a second sample from a separate lot at a second laboratory before publication.

Original laboratory report: PI-LAB-2025-114-report.pdf (document delivery arrives with the production storage backend)

More Tests, Cascade Research Group

Semaglutide
Purity 96.1% Discrepancy
Semaglutide
Purity 58.1% Failed
BPC-157
Purity 61.0% Failed

More Tests, GHK-Cu

GHK-Cu Halcyon Biosciences
Purity 98.2% Verified
GHK-Cu PureSci Labs
Purity 98.8% Verified
GHK-Cu Sterling Compound Co.
Purity 96.8% Verified